Get In Touch

Local Production Helps Maintain Regular Operations during COVID-19 Crisis

Analyzing the COVID-19 (coronavirus) situation is helping pharmaceutical companies to be better prepared in the upcoming months. Companies in the pharmaceutical water market are hard at work to keep up with regular orders whilst still supplying in demanding areas such as the Europe, the U.S., Russia, India, etc. Manufacturers are developing contingency plans to address future unprecedented situations. Flexibility is the key to maintain regular operations. Manufacturers in the pharmaceutical water market are increasing their research activities to flag alternatives pertaining to mission-critical suppliers and service providers.

Preparing for the unexpected is impossible; however, manufacturers should have a conceptual idea of steps to handle the situation of supply shortage. This will help businesses to withstand short-term crisis with minimized impact. Since the international trade is quite challenging in these unprecedented times, manufacturers are relying on local production.

Request a sample to get extensive insights into the Pharmaceutical Water Market

Innovations in Pharmaceutical-grade Water Purification Systems Bolster Market Growth

The pharmaceutical water market is predicted to cross a revenue of US$ 71.9 Bn by 2030. This is evident since manufacturers are innovating in pharmaceutical-grade water purification systems. For instance, Puretech designs water purification systems for pharmaceutical, cosmetics, and biopharma industries. Service providers are offering installation, commission, and validation of purification systems to pharmaceutical end users. Innovations in these systems are becoming prominent in European countries where regional manufacturers are strengthening their global distribution chains.

Equipment manufacturers are complying with worldwide pharmacopoeia standards. Cutting-edge water purification systems are helping manufacturers in the pharmaceutical water market to gain recognition. Equipment companies are meeting client specifications and requirements to increase the uptake of systems. Pre-treatment activities are fueling the demand for pharmaceutical-grade water purification systems. Region-specific needs are being catered by equipment manufacturers due to different degrees of pre-treatment methods.

Water Reuse Ensures Water Efficiency and Sustainability of Resources in Value Chain

The pharmaceutical industry is heavily dependent on different degrees of water purity. However, limitations in reuse of water are likely to affect growth of manufacturers in the pharmaceutical water market. Hence, manufacturers are increasing their focus in scientific and technical literature sources to innovate in new methods of water reuse. This is important since the pharmaceutical industry is a highly water-dependent economic sector.

As per the European Union (EU), pharmaceutical, agriculture, and chemical industries make a great contribution to the GDP (Gross Domestic Product) of the EU economy. The high demand for stable water supply has compelled manufacturers in the pharmaceutical water market to adopt water reuse practices. Water reuse is ensuring sustainability of water resources and is improving water efficiency in the value chain.

To understand how our report can bring difference to your business strategy, Ask for a brochure

Nanofiltration and Reverse Osmosis Aid in Removal of Contaminants

The selection of best filtration methods is critical in pharmaceutical applications. As such, ultrafiltration is being used to filter large particles and viruses. However, certain dissolved substances within the medium are unable to be removed by ultrafiltration. Hence, manufacturers in the pharmaceutical water market are increasing their R&D efforts to adopt alternative filtration processes such as nanofiltration and reverse osmosis. Thus, improved production practices are contributing toward the favorable growth of the market, which is estimated to progress at a CAGR of ~10% from 2020 to 2030.

Reverse osmosis is synonymous with the process of refining antibiotics and concentration of hormones within the pharmaceutical industry. Companies in the pharmaceutical water market are using filtration processes for plasma fractionation and red biotechnology.

Stuck in a neck-to-neck competition with other brands? Request a custom report on Pharmaceutical Water Market

Analysts’ Viewpoint

Nanofiltration and reverse osmosis methods are being highly publicized for killing viruses during filtration amidst the ongoing COVID-19 crisis. Pharmaceutical-grade water purification systems help to generate purified water, which is utilized in specialty enzymes, diagnostics, and white biotechnology applications. Technological innovations in these systems involve automatic thermal sanitization and continuous electrodeionisation. However, companies in the Europe pharmaceutical water market need to abide by stringent regulations of the EU. Hence, companies should adopt reuse practices for maintaining water efficiency and establishing sustainability of water resources in the value chain. This will help to maximize opportunities for safe reuse of different grades of water.

Pharmaceutical Water Market: Overview

  • According to Transparency Market Research’s latest research report on the global pharmaceutical water market for the historical period (2018–2019) and the forecast period (2020–2030), growth of biopharmaceutical and generic injectable drugs industries is projected to drive the global pharmaceutical water market in the near future
  • According to the report, the global pharmaceutical water market was valued at US$ 24.3 Bn in 2019 and is anticipated to expand at a CAGR of ~10% from 2020 to 2030

Growth of Biopharmaceutical and Generic Injectable Drugs Industries: Key Driver

  • Demand for biopharmaceuticals such as vaccines, proteins, antibodies, plasma, enzymes, biologics, and peptides is high for use in the production of life-saving medications. These biologicals are unstable in solution if stored over a long period of time.
  • The biopharmaceutical sector has expanded rapidly in the past few years. It is expected to grow at a rapid pace in the near future. Currently, the biopharmaceutical sector is valued at US$ 163 Bn. It is likely to expand at a CAGR of 8% over the next few years, nearly double that of the conventional pharmaceutical sector.
  • Growth of the biopharmaceutical industry can be attributed to large unmet medical needs in the treatment of chronic medical conditions, patent expiry of branded biologic drugs leading to development of biosimilar drugs, and a large number of clinical pipeline drugs. Moreover, rapid expansion of the vaccines industry is projected to propel the biopharmaceutical industry in the near future.
  • Players operating in the generic injectable market are focused on the development of generic injectable products, especially generic biologic products i.e., biosimilars
  • Presently, 28 biosimilar drugs have been approved by the U.S. FDA for the treatment of different types of chronic medical conditions
  • Increase in focus of leading players on the development and expansion of manufacturing facilities suitable for generic formulations is anticipated to boost the production of specialty generic injectable products during the forecast period
  • Development of generic formulations is a more rapid process compared to branded ones, as these products are exempt from the requirement to conduct clinical trials and toxicity studies. Large number of players are entering the global generic injectable market with cost-effective alternatives to branded products, leading to increased adoption of generic products.
  • Pharmaceutical water is an integral part of the biopharmaceutical and generic injectable industries. Hence, demand for pharmaceutical water is expected to increase, along with the expansion of the biopharmaceutical and generic injectable industries during the forecast period.

High Prevalence and Increase in Incidence of Diabetes: Major Driver

  • Rapid increase in burden of diabetes among the geriatric and obese population across the globe is a major factor likely to propel the global pharmaceutical water market during the forecast period
  • According to Diabetes Research and Clinical Practice, the global prevalence of diabetes was around 9.3% (463 million people) in 2019. The rate of prevalence is projected to increase to 10.2% (578 million) in 2030 and 10.9% (700 million) by 2045.
  • Globally, around 46% people with diabetes are still undiagnosed, which provides significant opportunity in the pharmaceutical water market
  • In the global diabetes care industry, the injectable drugs segment is anticipated to expand at a CAGR of 17.8%, compared to 15.1% of the total industry, and 11% of the oral anti-diabetics segment between 2009 and 2019
  • Around 7.4 million people in the U.S. with diabetes are expected to be taking one or more formulations of insulin
  • Nearly 2 million diabetic patients are prescribed with multiple daily injections

Pharmaceutical Water Market: Competition Landscape

  • This report profiles major players operating in the global pharmaceutical water market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments
  • The global pharmaceutical water market is moderately fragmented with the presence of a large number of leading players in the global market and several small players in regional markets. The top players hold major share of the global pharmaceutical water market.
  • Prominent players operating in the global pharmaceutical water market include
    • Merck KGaA,
    •  B. Braun Melsungen AG,
    • Baxter International, Inc.,
    • Thermo Fisher Scientific, Inc.,
    • Cytiva (Danaher),
    • Intermountain Life Sciences,
    • Standard Reagents, Pvt. Ltd.,
    • CovaChem, LLC.,
    • FUJIFILM Irvine Scientific,
    • Fresenius Kabi AG,
    • Pfizer, Inc.
  • The report on the global pharmaceutical water market discusses individual strategies, followed by company profiles of manufacturers of vaccines. The competition landscape section has been included in the report to provide readers with a dashboard view and a company market share analysis of key players operating in the global pharmaceutical water market.

Pharmaceutical Water Market – Scope of the Report

TMR’s report on the global pharmaceutical water market studies the past as well as current growth trends and opportunities to gain valuable insights of these indicators for the market during the forecast period from 2020 to 2030. The report provides the revenue of the global pharmaceutical water market for the period 2018–2030, considering 2019 as the base year and 2030 as the forecast year. The report also provides the compound annual growth rate (CAGR %) for the global pharmaceutical water market during the forecast period.

The report has been prepared after extensive primary and secondary researches. Primary research involved bulk of research efforts, wherein analysts carried out interviews with industry leaders and opinion makers. Secondary research involved referring to key players’ pharmaceutical water, annual reports, press releases, and relevant documents to understand the global pharmaceutical water market.

Secondary research also includes Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various phenomenon in the global pharmaceutical water market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Furthermore, the report sheds light on changing competitive dynamics in the global pharmaceutical water market. These indices serve as valuable tools for existing market players as well as for entities interested in entering the global pharmaceutical water market.

The report delves into the competition landscape of the global pharmaceutical water market. Key players operating in the global pharmaceutical water market have been identified, and each one of them has been profiled for their distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players in the global pharmaceutical water market that have been profiled in this report.

Key Questions Answered in Pharmaceutical Water Market Report

  • What is the scope of growth of devices and their companies in the global pharmaceutical water market and its application segment?
  • What will be the Y-o-Y growth of the global pharmaceutical water market between 2020 and 2030?
  • What is the influence of changing trends in technologies on the global pharmaceutical water market?
  • Will North America continue to be the most profitable regional market for pharmaceutical water providers?
  • Which factors will impede the growth of the global pharmaceutical water market during the forecast period?
  • Which are the leading companies in the global pharmaceutical water market?

Research Methodology

A unique research methodology has been utilized by TMR to conduct a comprehensive research on the growth of the global pharmaceutical water market and arrive at conclusions on the future growth prospects of the market. This research methodology is a combination of primary and secondary research, which helps analysts warrant the accuracy and reliability of the drawn conclusions.

Secondary sources referred to by analysts during the global pharmaceutical water market report include statistics from company annual reports, SEC filings, company websites, World Bank database, investor presentations, regulatory databases, government publications, and industry white papers. Analysts have also interviewed senior managers, device portfolio managers, CEOs, VPs, and market intelligence managers who contributed to TMR’s study on the global pharmaceutical water market’s primary sources.

These primary and secondary sources have provided exclusive information during interviews, which serves as a validation from pharmaceutical water market leaders. Access to an extensive internal repository and external proprietary databases allows this report to address specific details and questions about the global pharmaceutical water market with accuracy. The study also uses the top-down approach to assess the numbers for each segment and the bottom-up approach to counter-validate them. This has helped in reaching TMR’s estimates on future prospects of the global pharmaceutical water market more reliably and accurately.

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:

  • Customer Experience Maps
  • Insights and Tools based on data-driven research
  • Actionable Results to meet all the business priorities
  • Strategic Frameworks to boost the growth journey

The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.

The following regional segments are covered comprehensively:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.

Below is a snapshot of these quadrants.

1. Customer Experience Map

The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.

2. Insights and Tools

The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.

3. Actionable Results

The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.

4. Strategic Frameworks

The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

1. What can be the best investment choices for venturing into new product and service lines?

2. What value propositions should businesses aim at while making new research and development funding?

3. Which regulations will be most helpful for stakeholders to boost their supply chain network?

4. Which regions might see the demand maturing in certain segments in near future?

5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?

6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?

7. Which government regulations might challenge the status of key regional markets?

8. How will the emerging political and economic scenario affect opportunities in key growth areas?

9. What are some of the value-grab opportunities in various segments?

10. What will be the barrier to entry for new players in the market?

Pharmaceutical Water Market – Segmentation

Type

  • HPLC Grade Water
  • Water for Injection

End User

  • Pharmaceutical & Biotechnology Companies
  • Academics & Research Laboratories
  • Others (Medical Device Manufacturing)

Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Pharmaceutical Water Market

4. Market Overview

    4.1. Introduction

        4.1.1. Product Definition

        4.1.2. Industry Evolution / Developments

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. Global Pharmaceutical Water Market Analysis and Forecast, 2018–2030

        4.4.1. Market Revenue Projections (US$ Mn)

    4.5. Porter’s Five Force Analysis

5. Key Insights

    5.1. Pricing Analysis

    5.2. Technological Advancements

    5.3. Key Industry Events (mergers, acquisitions, collaborations, partnerships, etc.)

    5.4. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)

6. Global Pharmaceutical Water Market Analysis and Forecast, by Type

    6.1. Introduction & Definition

    6.2. Key Findings / Developments

    6.3. Global Pharmaceutical Water Market Value Forecast, by Type, 2018–2030

        6.3.1. HPLC Grade Water

        6.3.2. Water for Injection

    6.4. Global Pharmaceutical Water Market Attractiveness Analysis, by Type

7. Global Pharmaceutical Water Market Analysis and Forecast, by End-user

    7.1. Introduction & Definition

    7.2. Key Findings / Developments

    7.3. Global Pharmaceutical Water Market Value Forecast, by End-user, 2018–2030

        7.3.1. Pharmaceutical & Biotechnology Companies

        7.3.2. Academics & Research Laboratories

        7.3.3. Others (medical device manufacturing)

    7.4. Global Pharmaceutical Water Market Attractiveness Analysis, by End-user

8. Global Pharmaceutical Water Market Analysis and Forecast, by Region

    8.1. 10.1. Key Findings

    8.2. 10.2. Market Value Forecast, by Region

        8.2.1. North America

        8.2.2. Europe

        8.2.3. Asia Pacific

        8.2.4. Latin America

        8.2.5. Middle East & Africa

    8.3. Global Pharmaceutical Water Market Attractiveness Analysis, by Region

9. North America Pharmaceutical Water Market Analysis and Forecast

    9.1. Introduction

        9.1.1. Key Findings

    9.2. North America Pharmaceutical Water Market Value Forecast, by Type, 2018–2030

        9.2.1. HPLC Grade Water

        9.2.2. Water for Injection

    9.3. North America Pharmaceutical Water Market Value Forecast, by End-user, 2018–2030

        9.3.1. Pharmaceutical & Biotechnology Companies

        9.3.2. Academics & Research Laboratories

        9.3.3. Others (medical device manufacturing)

    9.4. North America Pharmaceutical Water Market Value Forecast, by Country, 2018–2030

        9.4.1. U.S.

        9.4.2. Canada

    9.5. North America Pharmaceutical Water Market Attractiveness Analysis

        9.5.1. By Type

        9.5.2. By Application

        9.5.3. By End-user

        9.5.4. By Country

10. Europe Pharmaceutical Water Market Analysis and Forecast

    10.1. Introduction

        10.1.1. Key Findings

    10.2. Europe Pharmaceutical Water Market Value Forecast, by Type, 2018–2030

        10.2.1. HPLC Grade Water

        10.2.2. Water for Injection

    10.3. Europe Pharmaceutical Water Market Value Forecast, by End-user, 2018–2030

        10.3.1. Pharmaceutical & Biotechnology Companies

        10.3.2. Academics & Research Laboratories

        10.3.3. Others (medical device manufacturing)

    10.4. Europe Pharmaceutical Water Market Value Forecast, by Country/Sub-region, 2018–2030

        10.4.1. Germany

        10.4.2. U.K.

        10.4.3. France

        10.4.4. Spain

        10.4.5. Italy

        10.4.6. Rest of Europe

    10.5. Europe Pharmaceutical Water Market Attractiveness Analysis

        10.5.1. By Type

        10.5.2. By Application

        10.5.3. By End-user

        10.5.4. By Country/Sub-region

11. Asia Pacific Pharmaceutical Water Market Analysis and Forecast

    11.1. Introduction

        11.1.1. Key Findings

    11.2. Asia Pacific Pharmaceutical Water Market Value Forecast, by Type, 2018–2030

        11.2.1. HPLC Grade Water

        11.2.2. Water for Injection

    11.3. Asia Pacific Pharmaceutical Water Market Value Forecast, by End-user, 2018–2030

        11.3.1. Pharmaceutical & Biotechnology Companies

        11.3.2. Academics & Research Laboratories

        11.3.3. Others (medical device manufacturing)

    11.4. Asia Pacific Pharmaceutical Water Market Value Forecast, by Country/Sub-region, 2018–2030

        11.4.1. China

        11.4.2. Japan

        11.4.3. India

        11.4.4. Australia & New Zealand

        11.4.5. Rest of Asia Pacific

    11.5. Asia Pacific Pharmaceutical Water Market Attractiveness Analysis

        11.5.1. By Type

        11.5.2. By Application

        11.5.3. By End-user

        11.5.4. By Country/Sub-region

12. Latin America Pharmaceutical Water Market Analysis and Forecast

    12.1. Introduction

        12.1.1. Key Findings

    12.2. Latin America Pharmaceutical Water Market Value Forecast, by Type, 2018–2030

        12.2.1. HPLC Grade Water

        12.2.2. Water for Injection

    12.3. Latin America Pharmaceutical Water Market Value Forecast, by End-user, 2018–2030

        12.3.1. Pharmaceutical & Biotechnology Companies

        12.3.2. Academics & Research Laboratories

        12.3.3. Others (medical device manufacturing)

    12.4. Latin America Pharmaceutical Water Market Value Forecast, by Country/Sub-region, 2018–2030

        12.4.1. Brazil

        12.4.2. Mexico

        12.4.3. Rest of Latin America

    12.5. Latin America Pharmaceutical Water Market Attractiveness Analysis

        12.5.1. By Type

        12.5.2. By Application

        12.5.3. By End-user

        12.5.4. By Country/Sub-region

13. Middle East & Africa Pharmaceutical Water Market Analysis and Forecast

    13.1. Introduction

        13.1.1. Key Findings

    13.2. Middle East & Africa Pharmaceutical Water Market Value Forecast, by Type, 2018–2030

        13.2.1. HPLC Grade Water

        13.2.2. Water for Injection

    13.3. Middle East & Africa Pharmaceutical Water Market Value Forecast, by End-user, 2018–2030

        13.3.1. Pharmaceutical & Biotechnology Companies

        13.3.2. Academics & Research Laboratories

        13.3.3. Others (medical device manufacturing)

    13.4. Middle East & Africa Pharmaceutical Water Market Value Forecast, by Country/Sub-region, 2018–2030

        13.4.1. GCC Countries

        13.4.2. South Africa

        13.4.3. Rest of Middle East & Africa

    13.5. Middle East & Africa Pharmaceutical Water Market Attractiveness Analysis

        13.5.1. By Type

        13.5.2. By Application

        13.5.3. By End-user

        13.5.4. By Country/Sub-region

14. Competition Landscape

    14.1. Market Player - Competition Matrix (by tier and size of companies)

    14.2. Market Share Analysis, by Company, 2019

    14.3. Company Profiles

        14.3.1. Merck KGaA

            14.3.1.1. Company Overview

            14.3.1.2. Company Financials

            14.3.1.3. Growth Strategies

            14.3.1.4. SWOT Analysis

        14.3.2. B. Braun Melsungen AG

            14.3.2.1. Company Financials

            14.3.2.2. Growth Strategies

            14.3.2.3. SWOT Analysis

        14.3.3. Baxter International, Inc.

            14.3.3.1. Company Overview

            14.3.3.2. Company Financials

            14.3.3.3. Growth Strategies

            14.3.3.4. SWOT Analysis

        14.3.4. Thermo Fisher Scientific, Inc.

            14.3.4.1. Company Overview

            14.3.4.2. Company Financials

            14.3.4.3. Growth Strategies

            14.3.4.4. SWOT Analysis

        14.3.5. Cytiva (Danaher)

            14.3.5.1. Company Overview

            14.3.5.2. Company Financials

            14.3.5.3. Growth Strategies

            14.3.5.4. SWOT Analysis

        14.3.6.  Intermountain Life Sciences

            14.3.6.1. Company Overview

            14.3.6.2. Company Financials

            14.3.6.3. Growth Strategies

            14.3.6.4. SWOT Analysis

        14.3.7. Standard Reagents, Pvt. Ltd.

            14.3.7.1.  Company Overview

            14.3.7.2. Company Financials

            14.3.7.3. Growth Strategies

            14.3.7.4. SWOT Analysis

        14.3.8. CovaChem, LLC.

            14.3.8.1. Company Overview

            14.3.8.2. Company Financials

            14.3.8.3. Growth Strategies

            14.3.8.4. SWOT Analysis

        14.3.9. FUJIFILM Irvine Scientific

            14.3.9.1. Company Overview

            14.3.9.2. Company Financials

            14.3.9.3. Growth Strategies

            14.3.9.4. SWOT Analysis

        14.3.10. Fresenius Kabi AG

            14.3.10.1. Company Overview

            14.3.10.2. Company Financials

            14.3.10.3. Growth Strategies

            14.3.10.4. SWOT Analysis

        14.3.11. Pfizer, Inc.

            14.3.11.1. Company Overview

            14.3.11.2. Company Financials

            14.3.11.3. Growth Strategies

            14.3.11.4. SWOT Analysis

        14.3.12. Other Prominent Key Players

List of Tables

Table 01: Global Pharmaceutical Water Market Value (US$ Mn) Forecast, by Type, 2018–2030

Table 02: Global Pharmaceutical Water Market Value (US$ Mn) Forecast, by End-user, 2018–2030

Table 03: Global Pharmaceutical Water Market Value (US$ Mn) Forecast, by Region, 2018–2030

Table 04: North America Pharmaceutical Water Market Value (US$ Mn) Forecast, by Country, 2018–2030

Table 05: North America Pharmaceutical Water Market Value (US$ Mn) Forecast, by Type, 2018–2030

Table 06: North America Pharmaceutical Water Market Value (US$ Mn) Forecast, by End-user, 2018–2030

Table 07: Europe Pharmaceutical Water Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

Table 08: Europe Pharmaceutical Water Market Value (US$ Mn) Forecast, by Type, 2018–2030

Table 09: Europe Pharmaceutical Water Market Value (US$ Mn) Forecast, by End-user, 2018–2030

Table 10: Asia Pacific Pharmaceutical Water Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

Table 11: Asia Pacific Pharmaceutical Water Market Value (US$ Mn) Forecast, by Type, 2018–2030

Table 12: Asia Pacific Pharmaceutical Water Market Value (US$ Mn) Forecast, by End-user, 2018–2030

Table 13: Latin America Pharmaceutical Water Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

Table 14: Latin America Pharmaceutical Water Market Value (US$ Mn) Forecast, by Type, 2018–2030

Table 15: Latin America Pharmaceutical Water Market Value (US$ Mn) Forecast, by End-user, 2018–2030

Table 16: Middle East & Africa Pharmaceutical Water Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030

Table 17: Middle East & Africa Pharmaceutical Water Market Value (US$ Mn) Forecast, by Type, 2018–2030

Table 18: Middle East & Africa Pharmaceutical Water Market Value (US$ Mn) Forecast, by End-user, 2018–2030

 

List of Figures

Figure 01: Global Pharmaceutical Water Market Value (US$ Mn) Forecast, 2018–2030

Figure 02: Global Pharmaceutical Water Market Value Share, by Region, 2019

Figure 03: Global Pharmaceutical Water Market Value Share, by Type, 2019

Figure 04: Global Pharmaceutical Water Market Value Share, by End-user, 2019

Figure 05: Global Pharmaceutical Water Market Value Share Analysis, by Type, 2019 and 2030

Figure 06: Global Pharmaceutical Water Market Attractiveness Analysis, by Type, 2020–2030

Figure 07: Global Pharmaceutical Water Market Revenue (US$ Mn), by HPLC Grade Water, 2018–2030

Figure 08: Global Pharmaceutical Water Market Revenue (US$ Mn), by Water for Injection, 2018–2030

Figure 09: Global Pharmaceutical Water Market Value Share Analysis, by End-user, 2019 and 2030

Figure 10: Global Pharmaceutical Water Market Attractiveness Analysis, by End-user, 2020–2030

Figure 11: Global Pharmaceutical Water Market Revenue (US$ Mn), by Pharmaceutical & Biotechnology Companies, 2018–2030

Figure 12: Global Pharmaceutical Water Market Revenue (US$ Mn), by Academics & Research Laboratories, 2018–2030

Figure 13: Global Pharmaceutical Water Market Revenue (US$ Mn), by Others, 2018–2030

Figure 14: Global Pharmaceutical Water Market Value Share Analysis, by Region, 2019 and 2030

Figure 15: Global Pharmaceutical Water Market Attractiveness Analysis, by Region, 2020–2030

Figure 16: North America Pharmaceutical Water Market Value (US$ Mn) Forecast, 2018–2030

Figure 17: North America Pharmaceutical Water Market Value Share Analysis, by Country, 2019 and 2030

Figure 18: North America Pharmaceutical Water Market Attractiveness Analysis, by Country, 2020–2030

Figure 19: North America Pharmaceutical Water Market Value Share Analysis, by Type, 2019 and 2030

Figure 20: North America Pharmaceutical Water Market Attractiveness Analysis, by Type, 2020–2030

Figure 21: North America Pharmaceutical Water Market Value Share Analysis, by End-user, 2019 and 2030

Figure 22: North America Pharmaceutical Water Market Attractiveness Analysis, by End-user, 2020–2030

Figure 23: Europe Pharmaceutical Water Market Value (US$ Mn) Forecast, 2018–2030

Figure 24: Europe Pharmaceutical Water Market Value Share Analysis, by Country/Sub-region, 2019 and 2030

Figure 25: Europe Pharmaceutical Water Market Attractiveness Analysis, by Country/Sub-region, 2020–2030

Figure 26: Europe Pharmaceutical Water Market Value Share Analysis, by Type, 2019 and 2030

Figure 27: Europe Pharmaceutical Water Market Attractiveness Analysis, by Type, 2020–2030

Figure 28: Europe Pharmaceutical Water Market Value Share Analysis, by End-user, 2019 and 2030

Figure 29: Europe Pharmaceutical Water Market Attractiveness Analysis, by End-user, 2020–2030

Figure 30: Asia Pacific Pharmaceutical Water Market Value (US$ Mn) Forecast, 2018–2030

Figure 31: Asia Pacific Pharmaceutical Water Market Value Share Analysis, by Country/Sub-region, 2019 and 2030

Figure 32: Asia Pacific Pharmaceutical Water Market Attractiveness Analysis, by Country/Sub-region, 2020–2030

Figure 33: Asia Pacific Pharmaceutical Water Market Value Share Analysis, by Type, 2019 and 2030

Figure 34: Asia Pacific Pharmaceutical Water Market Attractiveness Analysis, by Type, 2020–2030

Figure 35: Asia Pacific Pharmaceutical Water Market Value Share Analysis, by End-user, 2019 and 2030

Figure 36: Asia Pacific Pharmaceutical Water Market Attractiveness Analysis, by End-user, 2020–2030

Figure 37: Latin America Pharmaceutical Water Market Value (US$ Mn) Forecast, 2018–2030

Figure 38: Latin America Pharmaceutical Water Market Value Share Analysis, by Country/Sub-region, 2019 and 2030

Figure 39: Latin America Pharmaceutical Water Market Attractiveness Analysis, by Country/Sub-region, 2020–2030

Figure 40: Latin America Pharmaceutical Water Market Value Share Analysis, by Type, 2019 and 2030

Figure 41: Latin America Pharmaceutical Water Market Attractiveness Analysis, by Type, 2020–2030

Figure 42: Latin America Pharmaceutical Water Market Value Share Analysis, by End-user, 2019 and 2030

Figure 43: Latin America Pharmaceutical Water Market Attractiveness Analysis, by End-user, 2020–2030

Figure 44: Middle East & Africa Pharmaceutical Water Market Value (US$ Mn) Forecast, 2018–2030

Figure 45: Middle East & Africa Pharmaceutical Water Market Value Share Analysis, by Country/Sub-region, 2019 and 2030

Figure 46: Middle East & Africa Pharmaceutical Water Market Attractiveness Analysis, by Country/Sub-region, 2020–2030

Figure 47: Middle East & Africa Pharmaceutical Water Market Value Share Analysis, by Type, 2019 and 2030

Figure 48: Middle East & Africa Pharmaceutical Water Market Attractiveness Analysis, by Type, 2020–2030

Figure 49: Middle East & Africa Pharmaceutical Water Market Value Share Analysis, by End-user, 2019 and 2030

Figure 50: Middle East & Africa Pharmaceutical Water Market Attractiveness Analysis, by End-user, 2020–2030

 

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

Request Customization

Pharmaceutical Water Market